Approach to management of inflammatory bowel disease-related arthritis
Canadian IBD Today · 2023
DOI: 10.58931/cibdt.2023.118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian IBD Today, 2023. Verfasst von May Y. Choi und 1 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The most common extraintestinal manifestation of inflammatory bowel disease (IBD) is arthropathy. These conditions have been reported in up to 50% of patients with IBD and are more common in Crohn’s’ disease (CD), particularly colonic disease, and in females. IBD-associated arthritis is classified as a type of spondyloarthritis (SpA). The treatment is dependent on the type of SpA involvement, which can be subdivided into peripheral and/or axial disease. The treatment approach consists of a combination of non-pharmacological and pharmacological therapies managed by a multidisciplinary team and is based on collaborative decisions between gastroenterology and rheumatology. In light of rapidly expanding therapeutic armamentaria for both immune-mediated arthritis and IBD, this paper will provide an overview of an approach to the treatment of arthritis associated with IBD, considering recommendations by recent guidelines and novel therapies.
Zitieren
APA
Choi, M. Y., & Mosher, D. (2023). Approach to management of inflammatory bowel disease-related arthritis. Canadian IBD Today. https://doi.org/10.58931/cibdt.2023.118
Vancouver
Choi MY, Mosher D. Approach to management of inflammatory bowel disease-related arthritis. Canadian IBD Today. 2023. doi:10.58931/cibdt.2023.118
BibTeX
@article{Choi2023,
author = {Choi, May Y. and Mosher, Dianne},
title = {Approach to management of inflammatory bowel disease-related arthritis},
journal = {Canadian IBD Today},
year = {2023},
doi = {10.58931/cibdt.2023.118}
}
EUVIMED